These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 14738053)

  • 1. [Controversial effects of aspirin on coronary artery disease and chronic heart failure].
    Xu CB
    Zhonghua Nei Ke Za Zhi; 2003 Sep; 42(9):603-4. PubMed ID: 14738053
    [No Abstract]   [Full Text] [Related]  

  • 2. Is aspirin safe for patients with heart failure?
    Cleland JG; Bulpitt CJ; Falk RH; Findlay IN; Oakley CM; Murray G; Poole-Wilson PA; Prentice CR; Sutton GC
    Br Heart J; 1995 Sep; 74(3):215-9. PubMed ID: 7547012
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin and coronary artery diseases.
    Jauhari J
    J Indian Med Assoc; 1993 Mar; 91(3):50-1. PubMed ID: 8349998
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure.
    McAlister FA; Ghali WA; Gong Y; Fang J; Armstrong PW; Tu JV
    Circulation; 2006 Jun; 113(22):2572-8. PubMed ID: 16735672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin use in chronic heart failure: what should we recommend to the practitioner?
    Massie BM
    J Am Coll Cardiol; 2005 Sep; 46(6):963-6. PubMed ID: 16168276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ivabradine: heart rate reduction in coronary heart disease and chronic heart failure].
    Bruhn C
    Med Monatsschr Pharm; 2012 Jun; 35(6):202-8. PubMed ID: 22808664
    [No Abstract]   [Full Text] [Related]  

  • 7. A mechanistic interaction remains to be determined for elevated NTproBNP in heart failure patients receiving both an ACE inhibitor and aspirin.
    McLachlan CS; Zhang Z; Mossop P
    J Card Fail; 2007 Feb; 13(1):75-6. PubMed ID: 17339006
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin use in older patients with heart failure and coronary artery disease: national prescription patterns and relationship with outcomes.
    Masoudi FA; Wolfe P; Havranek EP; Rathore SS; Foody JM; Krumholz HM
    J Am Coll Cardiol; 2005 Sep; 46(6):955-62. PubMed ID: 16168275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Which interactions are there for equal doses of acetylsalicylic acid and ACE inhibitors?].
    Joost HG
    Dtsch Med Wochenschr; 2003 Feb; 128(8):398. PubMed ID: 12594628
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin and coronary heart disease. Clinical applications.
    Koutts J
    Aust Fam Physician; 1990 Feb; 19(2):217, 221-3. PubMed ID: 2322188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of aspirin in ischemic heart disease].
    Frishman W; Horwitz S
    Arch Inst Cardiol Mex; 1977; 47(2):129-31. PubMed ID: 901049
    [No Abstract]   [Full Text] [Related]  

  • 12. On call. I reread your articles on congestive heart failure when I was diagnosed with the condition last month. My breathing is back to normal, and I feel well. My doctor has prescribed all the medications you recommended, but he disagreed with one. He said that since I'm taking Vasotec, I should stop my aspirin. Do you agree?
    Simon HB
    Harv Mens Health Watch; 2006 Feb; 10(7):8. PubMed ID: 18828217
    [No Abstract]   [Full Text] [Related]  

  • 13. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.
    Ezekowitz J; McAlister FA; Humphries KH; Norris CM; Tonelli M; Ghali WA; Knudtson ML;
    J Am Coll Cardiol; 2004 Oct; 44(8):1587-92. PubMed ID: 15489090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin resistance: disparities and clinical implications.
    Airee A; Draper HM; Finks SW
    Pharmacotherapy; 2008 Aug; 28(8):999-1018. PubMed ID: 18657017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comments in response to "low-dose aspirin increases aspirin resistance in patients with coronary artery disease".
    Fisher M; Knappertz V
    Am J Med; 2006 Mar; 119(3):287; author reply 287-8. PubMed ID: 16490484
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of low dose aspirin on cardiorenal function and acute hemodynamic response to enalaprilat in a canine model of severe heart failure.
    Evans MA; Burnett JC; Redfield MM
    J Am Coll Cardiol; 1995 May; 25(6):1445-50. PubMed ID: 7722147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the effect of angiotensin receptor blockade in patients with heart failure modified by treatment with aspirin? The answer is not so clear!
    Massie BM
    Eur J Heart Fail; 2010 Jul; 12(7):639-41. PubMed ID: 20576831
    [No Abstract]   [Full Text] [Related]  

  • 18. Combining aspirin with angiotensin converting enzyme inhibitors in heart failure: how safe is it?
    Mehta H; Mahajan A; Bansal N; Vaidya S; Pathak L
    J Assoc Physicians India; 1998 Nov; 46(11):953-6. PubMed ID: 11229224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin and coronary artery disease.
    Mehrotra TN; Katira R
    J Indian Med Assoc; 1991 Aug; 89(8):215-6. PubMed ID: 1748796
    [No Abstract]   [Full Text] [Related]  

  • 20. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.